Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cumberland Pharmaceu (CPIX)

Cumberland Pharmaceu (CPIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 71,365
  • Shares Outstanding, K 15,184
  • Annual Sales, $ 40,740 K
  • Annual Income, $ -6,960 K
  • 60-Month Beta 0.14
  • Price/Sales 1.84
  • Price/Cash Flow 65.94
  • Price/Book 1.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year 0.08
  • Growth Rate Est. (year over year) -112.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.19 +14.39%
on 11/21/19
5.80 -17.41%
on 11/12/19
-0.71 (-12.91%)
since 10/21/19
3-Month
4.19 +14.39%
on 11/21/19
6.10 -21.48%
on 10/07/19
-0.75 (-13.54%)
since 08/21/19
52-Week
4.19 +14.39%
on 11/21/19
6.99 -31.47%
on 05/20/19
-1.44 (-23.11%)
since 11/21/18

Most Recent Stories

More News
Cumberland: 3Q Earnings Snapshot

NASHVILLE, Tenn. (AP) _ Cumberland Pharmaceuticals Inc. (CPIX) on Tuesday reported a loss of $2 million in its third quarter.

CPIX : 4.79 (+1.91%)
Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology today announced third quarter 2019 financial results with net revenues...

CPIX : 4.79 (+1.91%)
N-acetylcysteine (CAS 616-91-1) Market 2019 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2025

The report provides rational insights along with historical and forecast data to aid in better understanding of the Global N-acetylcysteine (CAS 616-91-1) Market. The report provides a comprehensive analysis...

CPIX : 4.79 (+1.91%)
Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.56 in the latest trading session, marking a -0.18% move from the prior day.

CPIX : 4.79 (+1.91%)
What's in Store for Cumberland Pharma (CPIX) in Q3 Earnings?

Cumberland Pharmaceuticals' (CPIX) third-quarter results are expected to reflect solid sales growth.

FOLD : 9.46 (-1.56%)
TBPH : 17.90 (+1.70%)
CPIX : 4.79 (+1.91%)
EYEN : 3.38 (+4.97%)
Cumberland Pharmaceuticals (CPIX) to Report Q3 Results: Wall Street Expects Earnings Growth

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPIX : 4.79 (+1.91%)
Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2019 financial results after the market closes on Tuesday, November 12, 2019. A conference call and live...

CPIX : 4.79 (+1.91%)
Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.34 in the latest trading session, marking a +0.75% move from the prior day.

CPIX : 4.79 (+1.91%)
Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.30 in the latest trading session, marking a -1.6% move from the prior day.

CPIX : 4.79 (+1.91%)
Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know

Cumberland Pharmaceuticals (CPIX) closed at $5.44 in the latest trading session, marking a -1.72% move from the prior day.

CPIX : 4.79 (+1.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

The current trending strength of the market is Strong.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CPIX with:

Business Summary

Cumberland Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is a specialty pharmaceutical company focused on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The company's lead product candidate, Amelior, which is in...

See More

Key Turning Points

2nd Resistance Point 5.19
1st Resistance Point 4.99
Last Price 4.79
1st Support Level 4.39
2nd Support Level 3.99

See More

52-Week High 6.99
Fibonacci 61.8% 5.92
Fibonacci 50% 5.59
Fibonacci 38.2% 5.26
Last Price 4.79
52-Week Low 4.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar